Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs

Written by: Annenberg Center for Health Sciences
Listen for free

  • Summary

  • Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.
    Annenberg Center for Health Sciences
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
Episodes
  • Clinical Case Vignettes

    Clinical Case Vignettes
    Nov 14 2024
    • Initiating triheptanoin
    • Dosing modification to improve tolerability
    Show more Show less
    10 mins
  • Optimizing Triheptanoin Therapy

    Optimizing Triheptanoin Therapy
    Nov 14 2024
    • Clinical safety and efficacy
    • Initiation and titration
    • Administration considerations
    • Individualizing treatment
    Show more Show less
    19 mins
  • Historical Treatment; Introduction of Triheptanoin

    Historical Treatment; Introduction of Triheptanoin
    Nov 14 2024
    • Dietary modification
    • MCT supplementation
    • Triheptanoin mechanism of action
    Show more Show less
    6 mins

What listeners say about Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews
No reviews are available